Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-06-19Clinical Trial Update: Behavioural Activation-Based Treatment Administered Through Smartphone [NA]
This clinical trial evaluated smartphone-delivered behavioral activation therapy for depression and is now completed. The study was sponsore…
-
CLINICAL_TRIALS trial_result · 2013-06-18Clinical Trial Update: Randomized Controlled Trial of Cognitive Therapy Based Self Help Manual for Depression [NA]
This entry notes the completion of a randomized controlled trial evaluating a cognitive therapy-based self-help manual for depression.
-
CLINICAL_TRIALS research · 2013-06-13Clinical Trial Update: Escitalopram in Depressive Patients With Acute Coronary Artery Syndrome [Phase 4]
A Phase 4 clinical trial update indicates completion of a study evaluating escitalopram in patients with depression and acute coronary syndr…
-
CLINICAL_TRIALS trial_result · 2013-06-12Clinical Trial Update: Open-label Study of Curcumin C-3 Complex in Schizophrenia [Phase 1, Phase 2]
An open-label Phase 1/2 study of Curcumin C-3 Complex in schizophrenia and schizoaffective disorder has completed.
-
FDA approval · 2013-06-12FDA Approved: ESCITALOPRAM ORAL SOLUTION — Original Application (Chartwell RX, LLC)
FDA approved a generic escitalopram oral solution from Chartwell RX, LLC under an Original Application (ANDA). It is indicated for major dep…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-06-11Clinical Trial Update: Cost- Effectiveness Study of Brief Interventions for Mood and Anxiety Disorders [NA]
This completed clinical trial evaluates the cost-effectiveness of brief interventions for mood and anxiety disorders.
-
FDA approval · 2013-06-10FDA Approved: ESCITALOPRAM — Supplemental Application (Accord Healthcare Inc.)
FDA approved Accord Healthcare Inc.'s supplemental application for escitalopram (generic) under ANDA202389. This approval marks a supplement…
-
CLINICAL_TRIALS trial_result · 2013-06-10Clinical Trial Update: Japanese Phase 1 Multiple Ascending Dose (MAD) Study [Phase 1]
Bristol-Myers Squibb completed a Japanese Phase 1 multiple ascending dose study for a depression candidate.
-
FDA approval · 2013-06-08FDA Approved: VIIBRYD — Supplemental Application (Allergan, Inc.)
The FDA approved Allergan's supplemental application for Viibryd (vilazodone hydrochloride). The action pertains to a supplemental submissio…
-
CLINICAL_TRIALS research · 2013-06-06Clinical Trial Update: Investigating the Impact of Mode of Administration on Item Response
This clinical trial update reports on an investigation into how mode of administration affects item response across conditions including chr…
-
CLINICAL_TRIALS trial_result · 2013-06-06Clinical Trial Update: Effects of Sevoflurane and Ketamine on QT in Electroconvulsive Therapy [Phase 4]
Phase 4 study evaluating the effects of sevoflurane and ketamine on QT interval during electroconvulsive therapy in patients with major depr…
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: Free Venlafaxine Treatment for Marijuana Addiction and Depression - 1 [Phase 2]
Phase 2 trial updating results on free venlafaxine treatment for depression associated with marijuana abuse.
-
CLINICAL_TRIALS trial_result · 2013-06-03Clinical Trial Update: Neuro-modulation of the Depressed Brain Using Working Memory Training and Transcranial Direct Current Stimulation (tDCS) [Phase 2]
A Phase 2 study examining neuro-modulation of depression using working memory training plus transcranial direct current stimulation (tDCS) h…
-
CLINICAL_TRIALS trial_result · 2013-06-03Clinical Trial Update: Interpersonal Psychotherapy for Depression in People With Heart Failure [Phase 1, Phase 2]
A clinical trial evaluating interpersonal psychotherapy for depression in people with heart failure has completed Phase 1 and Phase 2.
-
FDA approval · 2013-05-31FDA Approved: ESCITALOPRAM OXALATE — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for escitalopram oxalate from Rising Pharma Holdings, Inc., approving a generic version under the AN…
-
FDA approval · 2013-05-31FDA Approved: ESCITALOPRAM — Supplemental Application (Aurobindo Pharma Limited)
FDA approved the supplemental application for escitalopram oxalate by Aurobindo Pharma Limited, enabling continued generic production and di…
-
CLINICAL_TRIALS research · 2013-05-31Clinical Trial Update: Behavioral Insomnia Therapy For Those With Insomnia and Depression [NA]
Clinical trial update on Behavioral Insomnia Therapy for people with insomnia and major depressive disorder. The current status of the study…
-
EMA guidance · 2013-05-30European Medicines Agency publishes guideline on clinical investigation of medicines for depression
EMA published a guideline detailing the design and conduct of clinical investigations for medicines treating depression.
-
CLINICAL_TRIALS trial_result · 2013-05-30Clinical Trial Update: Stress Management Training in Patients Undergoing Radiation Therapy for Cancer [NA]
This clinical trial update summarizes the completion of a study evaluating stress management training for cancer patients undergoing radiati…
-
CLINICAL_TRIALS trial_result · 2013-05-30Clinical Trial Update: Effects of Interpersonal Psychotherapy on Depression During and After Pregnancy [NA]
Completed clinical trial evaluating the effect of interpersonal psychotherapy on depression during and after pregnancy.
-
CLINICAL_TRIALS trial_result · 2013-05-29Clinical Trial Update: Depression Prevention Program for American Indian Adolescents During and After Pregnancy [NA]
Completed clinical trial evaluating a depression prevention program for American Indian adolescents during and after pregnancy.
-
CLINICAL_TRIALS research · 2013-05-29Clinical Trial Update: Geriatric Psychiatry and Pharmacovigilance
An update on a geriatric psychiatry trial from Hannover Medical School; no trial status or results are provided. The study covers dementia, …
-
CLINICAL_TRIALS trial_result · 2013-05-23Clinical Trial Update: Transcranial Magnetic Stimulation for Treating Women With Chronic Widespread Pain [Phase 2]
Phase 2 clinical trial evaluating transcranial magnetic stimulation for chronic widespread pain in women with fibromyalgia. The study has co…
-
CLINICAL_TRIALS trial_result · 2013-05-22Clinical Trial Update: Effectiveness of the Screen, Test, Immunize, Reduce Risk, and Refer (STIRR) Intervention for People With Both a Mental and Substance Abuse Disorder [Phase 2]
Phase 2 clinical trial evaluating the STIRR intervention for people with co-occurring mental illness and substance use disorders; results we…
-
FDA approval · 2013-05-21FDA Approved: ESCITALOPRAM OXALATE — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approved a supplemental application for escitalopram oxalate from Macleods Pharmaceuticals Limited, allowing the generic product to be m…